Cost-effectiveness, contraception, etonogestrel, implanon, implants, levonorgestrel, economic evaluation
Phlebitis, pheripheral venous catheter, risk factors, nursing care, economic impact
Access to essential medicines and health technologies, clinical research, mucopolysaccharidosis II, rare diseases
Chronic obstructive pulmonary disease, exacerbation, costs and cost analysis, supplemental health
Ovarian neoplasms, analysis of the budgetary impact of therapeutic advances, poly (ADP-ribose) polymerase inhibitors, real-world evidence
Sleep, disorders of excessive somnolence, sleep apnea syndromes, intrinsic sleep disorders, public health, public policy, health economics
TAVI, systematic review, economic analysis, cost-effectiveness analysis, cost-utility analysis
#VALOR!
Health Technology Assessment, orphan drugs, rare disease
Anxiety, private setting, economic burden, database, expert opinion
Burden, depression, private healthcare system, database, expert opinion
Methodological guidelines